Tandem Diabetes Care Inc (TNDM)
44.33
-0.03
(-0.07%)
USD |
NASDAQ |
May 13, 13:44
Tandem Diabetes Care Cash from Investing (Quarterly): -5.056M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -5.056M |
December 31, 2023 | -16.58M |
September 30, 2023 | -48.52M |
June 30, 2023 | 5.698M |
March 31, 2023 | -26.33M |
December 31, 2022 | 35.78M |
September 30, 2022 | -14.16M |
June 30, 2022 | 6.357M |
March 31, 2022 | 5.197M |
December 31, 2021 | -76.82M |
September 30, 2021 | -39.20M |
June 30, 2021 | -64.76M |
March 31, 2021 | -6.094M |
December 31, 2020 | -59.63M |
September 30, 2020 | -137.82M |
June 30, 2020 | -131.52M |
March 31, 2020 | 32.92M |
December 31, 2019 | -20.90M |
September 30, 2019 | -22.17M |
June 30, 2019 | -14.66M |
March 31, 2019 | 0.778M |
December 31, 2018 | -6.591M |
September 30, 2018 | -46.81M |
Date | Value |
---|---|
June 30, 2018 | -27.82M |
March 31, 2018 | -9.514M |
December 31, 2017 | -1.419M |
September 30, 2017 | -0.244M |
June 30, 2017 | 1.838M |
March 31, 2017 | 2.607M |
December 31, 2016 | 4.575M |
September 30, 2016 | 5.828M |
June 30, 2016 | 1.681M |
March 31, 2016 | -1.636M |
December 31, 2015 | 8.86M |
September 30, 2015 | 11.53M |
June 30, 2015 | 0.305M |
March 31, 2015 | -18.27M |
December 31, 2014 | 7.509M |
September 30, 2014 | -15.15M |
June 30, 2014 | 2.794M |
March 31, 2014 | -30.63M |
December 31, 2013 | -6.575M |
September 30, 2013 | -2.614M |
June 30, 2013 | -0.515M |
March 31, 2013 | -1.401M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-137.82M
Minimum
Sep 2020
35.78M
Maximum
Dec 2022
-29.91M
Average
-18.74M
Median
Cash from Investing (Quarterly) Benchmarks
Insulet Corp | -24.00M |
Stryker Corp | -408.00M |
Abbott Laboratories | -425.00M |
Integer Holdings Corp | -168.20M |
Twist Bioscience Corp | -5.24M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -7.996M |
Cash from Financing (Quarterly) | 13.59M |
Free Cash Flow | -66.71M |
Free Cash Flow Per Share (Quarterly) | -0.1906 |
Free Cash Flow to Equity (Quarterly) | -74.92M |
Free Cash Flow to Firm (Quarterly) | -12.45M |
Free Cash Flow Yield | -2.31% |